• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, May 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell

Bioengineer by Bioengineer
February 4, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

‘Moreover, it was revealed that the complex of YAP1, CLDN4, and zona occludens-2 was formed by CPE treatment, further suppressing YAP1 phosphorylation by LATS1 and activating it.’

IMAGE

Credit: Correspondence to – Yi Luo – [email protected] – Tadaaki Kirita – [email protected] – Hiroki Kuniyasu – [email protected]


Oncotarget Volume 11, Issue 4: Treatment of human oral squamous cell carcinoma cell lines HSC3 and HSC4 with Clostridium perfringens enterotoxin, induced CLDN4 nuclear translocation to enhance epithelial-mesenchymal transition, stemness, cell proliferation, and invasive ability.

Moreover, it was revealed that the complex of YAP1, CLDN4, and zona occludens-2 was formed by CPE treatment, further suppressing YAP1 phosphorylation by LATS1 and activating it.

Dr. Yi Luo from the Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu Province 226001, China, Dr. Tadaaki Kirita from the Department of Oral and Maxillofacial Surgery, Nara Medical University, Kashihara, Nara, Japan and Dr. Hiroki Kuniyasu from the Department of Molecular Pathology, Nara Medical University, Kashihara, Nara, Japan said in their Oncotarget research article, “More than 300 species of bacteria are found in the oral cavity, 10% of which are anaerobic in nature”

The number of bacteria in the oral cavity is determined by scraping the gingiva.

Mostly the normal count of bacteria is about 1011 to 1012 cfu/ml and of these 0.1% are anaerobic.

It is still unclear what role oral bacteria play exactly in the development of oral cancer.

In contrast, zonula occludens -1 and ZO-2, which are lining proteins in tight junctions, activate yes-associated protein and transcriptional coactivator with PDZ-binding motif by inhibiting the Hippo signaling pathway, promoting cancer cell growth and epithelial-mesenchymal transition to enhance cancer metastasis.

In this study, the authors examined the role of the bacteria in the oral cavity, especially anaerobic bacteria, in the development of oral cancer through the action on CLDN protein.

We showed that anaerobic bacteria impair tight junctions and promote cancer progression through YAP1 activation in oral squamous cell carcinomas.

The Luo/Kirita/Kuniyasu Research Team concluded that their Oncotarget study inferred that Clostridium induced YAP1 activation, which in turn suggested that the suppression of Clostridium by antibiotics and/or oral hygiene might contribute to the suppression of carcinogenesis and cancer progression. Extensive clinical studies are required to prove this hypothesis in the future.

###

Sign up for free Altmetric alerts about this article

Full text – https://doi.org/10.18632/oncotarget.27424

Correspondence to – Yi Luo – [email protected] – Tadaaki Kirita – [email protected] – Hiroki Kuniyasu – [email protected]

Keywords – lostridium perfringens enterotoxin, claudin-4, YAP, Hippo signal, oral squamous cell carcinoma, Pathology

About Oncotarget

Oncotarget is a weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit http://www.oncotarget.com or connect with @Oncotarget

Oncotarget is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls

Media Contact

18009220957×105

[email protected]

Media Contact
@RYANJAMESJESSUP
[email protected]
202-638-9720

Original Source

http://www.oncotarget.com/news/pr/clostridium-perfringens-enterotoxin-induces-claudin-4-to-activate-yap-in-oral-squamous-cell-carcinomas/

Related Journal Article

http://dx.doi.org/10.18632/oncotarget.27424

Tags: cancerCarcinogensMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Evaluating Digoxin Use in Patients with Symptomatic Rheumatic Heart Disease

May 10, 2026

Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure

May 10, 2026

Urdu Fall Risk Questionnaire Adapted for Elderly

May 10, 2026

Key Pharmacological Markers for HIV Prevention in MSM

May 10, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    840 shares
    Share 336 Tweet 210
  • New Study Reveals Plants Can Detect the Sound of Rain

    727 shares
    Share 290 Tweet 181
  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    68 shares
    Share 27 Tweet 17
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evaluating Digoxin Use in Patients with Symptomatic Rheumatic Heart Disease

Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure

Urdu Fall Risk Questionnaire Adapted for Elderly

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.